Skip to Main Content

NOTICE
MyAANS, password-protected resources, and purchases are currently experiencing issues and are unavailable. We are working to get this fixed as soon as possible.

Registry for the Advancement of DBS in Parkinson’s Disease (RAD-PD)

The Registry for the Advancement of Deep Brain Stimulation in Parkinson’s Disease (RAD-PD) was recently launched with funding from the Michael J. Fox Foundation (MJFF) and oversight by a steering committee, comprised of five lead physician investigators, representatives from MJFF, the NPA, NeuroTargeting technology and industry. The NPA will provide registry management and NeuroTargeting will provide the use of its technology platform, CranialCloud™. Thirty-two sites have been invited to participate in competitive activation with seven tier-1 sites and three tier-2 sites in the first and second years, totaling 20 sites in the initial period. Sites will enroll their first patients upon completion of the site agreements, IRB review and training in the last quarter of 2018.

10-26 E-news-TOC